论文部分内容阅读
近年来,肺癌在我国的发病率及死亡率不断上升,现已占男性恶性肿瘤之首位,而鳞癌在肺癌中比例高达40～60％,对局限于肺部的晚期鳞癌患者(已失去手术机会),我院从1992年以来,采用西药顺氯氨铂及足叶乙甙联合方案(PE方案)结合中药自拟方清热润肺汤,治疗局限性肺癌的中晚期取得了较好疗效。 1.对象与方法 病例选择1992年9月～1998年12月在我院住院经病理证实,并经临床、X线、CT及纤维支气管镜检查,根据1985年WHO分期标准确定分期的肺鳞癌患者进行前瞻性研究,经至少一疗程化疗及应用中草药共53例,其中男47例,女6例,年龄39～82,平均57±9岁。
In recent years, the incidence and mortality of lung cancer in China have been on the rise, and now account for the first place in male malignant tumors. The proportion of squamous cell carcinoma in lung cancer is as high as 40 to 60%, and patients with advanced squamous cell carcinoma confined to the lung have been lost. Surgical Opportunities) Since 1992, our hospital has used western medicine cisplatin and the combination of acetylcholine and acetylcholine (PE) combined with Chinese herbal formula Fangqing heat Runfei Tang for treatment of locally advanced lung cancer. . 1. Subjects and Methods Case selection From September 1992 to December 1998, hospitalization in our hospital was confirmed by pathology, and clinical, X-ray, CT and fiberoptic bronchoscopy were performed to determine stages of lung squamous cell carcinoma according to the 1985 WHO staging criteria. The patients were prospectively studied. At least one course of chemotherapy and Chinese herbal medicine were applied in 53 cases, including 47 males and 6 females, aged 39-82, with an average age of 57±9 years.